HUM vs RAPP
Humana Inc (HUM) versus Rapport Therapeutics, Inc. Common Stock (RAPP) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Rapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
RAPP does not have a complete income-statement cache yet.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. RAPP currently screens at market cap $532.9M.
Not investment advice. Open the HUM and RAPP stock pages for the full models.
Not investment advice.